Palabras clave
Cysticercus cellulosae
imunofluorescência indireta
hemaglutinação indireta
Cómo citar
Resumen
Neste estudo foram analisados os resultados obtidos do diagnóstico de cisticercose no Centro de Imunologia do Instituto Adolfo Lutz (IAL), no período de março/2007 a julho/2010. A detecção de anticorpos específicos em 522 amostras de soro e líquido cefalorraquidiano (LCR) foi realizada pelas técnicas de imunofluorescência indireta (IFI) e hemaglutinação indireta (HAI). A frequência de amostras reagentes foi de 11,0% no LCR e 8,2% no soro. Em 50% das amostras não houve informações sobre suspeita clínica de neurocisticercose dos pacientes, sendo disponíveis nos 18,3% e 16,4%, em amostras, respectivamente, de LCR e soro. Nas amostras de paciente com suspeita de neurocisticercose, a positividade foi de 22,6% (LCR) e de 18,4% (soro). Houve associação entre a suspeita clínica e a positividade dos testes (p>0.05). A maioria das amostras testadas foi proveniente do Estado de São Paulo, e 16,9% de amostras de LCR e 35,9% de amostras séricas foram enviados de outros Estados do país. Os ensaios de IFI e HAI apresentaram teste de concordância Kappa de 86%. Pela indisponibilidade de kits de reagentes diagnósticos de cisticercose em amostras de LCR no mercado, os testes in-house produzidos no IAL têm sido de grande relevância para os serviços de saúde pública.
Citas
1. Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis. Parasitol Int. 2006;55(Suppl 1):S111-5.
2. OPAS. Organização Panamericana de Saúde. Epidemiologia y control de la teníase / cisticercosis en América Latina. Washington; 1994. Versão 3.0.
3. Agapejev S. Clinical and epidemiological aspects of neurocysticercosis in Brazil: a critical approach. Arq Neuro-psiquiatr. 2003;61(3B):822-8.
4. Machado AB, Pialarissi CS, Vaz AJ. Human cysticercosis diagnosed at a general hospital, São Paulo, SP (Brazil). Rev Saúde Pública. 1988;22(3):240-4.
5. Mendes EC, Silva SS, Fonseca EA, Souza HR, Carvalho RW. Human neurocysticercosis in Baixada Fluminense, Rio de Janeiro State, Brazil. Arq Neuro-psiquiatr. 2005;63(4):1058-62.
6. Chimelli L, Lovalho AF, Takayanagui OM. Neurocysticercosis: contribution of autopsies in the consolidation of mandatory notification in Ribeirao Preto-SP, Brazil. Arq Neuro-psiquiatr. 1998;56(3B):577-84.
7. Lino-Junior RS, Faleiros AC, Vinaud MC, Oliveira FA, Guimarães JV, Reis MA, et al. Anatomopathological aspects of neurocysticercosis in autopsied patients. Arq Neuro-psiquiatr. 2007;65(1):87-91.
8. Trevisol-Bittencourt PC, Silva NC, Figueredo R. Prevalence of neurocysticercosis among epileptic in-patients in the west of Santa Catarina-southern Brazil. Arq Neuro-psiquiatr. 1998;56(1):53-8.
9. Grazziotin AL, Fontalvo MC, Santos MB, Monego F, Kolinski VH, Bordignon RH, et al. Epidemiologic pattern of patients with neurocysticercosis diagnosed by computed tomography in Curitiba, Brazil. Arq Neuro-psiquiatr. 2010;68(2):269-72.
10. Narata AP, Arruda WO, Uemura E, Yukita S, Blume AG, Suguiura C, et al. Neurocysticercosis. A tomographic diagnosis in neurological patients. Arq Neuro-psiquiatr. 1998;56(2):245-9.
11. Del Brutto OH, Sotelo J. Neurocysticercosis: an update. Rev Infect Dis. 1988;10(6):1075-87.
12. Livramento JA. Contribution of immunofluorescent reactions in the cerebrospinal fluid to the study of neurocysticercosis. Arq Neuro-psiquiatr. 1981;39(3):261-78.
13. Ferreira AP, Vaz AJ, Nakamura PM, Sasaki AT, Ferreira AW, Livramento JA. Hemagglutination test for the diagnosis of human neurocysticercosis: development of a stable reagent using homologous and heterologous antigens. Rev Inst Med Trop São Paulo. 1997;39(1):29-33.
14. Pialarissi CS, Vaz AJ, de Souza AM, Nakamura PM, Camargo ED, Silva MV, et al. Comparative study of serological tests in the immunological diagnosis of neurocysticercosis. Rev Inst Med Trop São Paulo. 1987;29(6):367-73.
15. Costa JM. Immunoenzymatic test (ELISA) in the diagnosis of neurocysticercosis: study of various antigenic extracts in the detection of IgG antibodies in serum and cerebrospinal fluid samples. Arq Neuro-psiquiatr. 1986;44(1):15-31.
16. Molinari JL, Garcia-Mendoza E, de la Garza Y, Ramirez JA, Sotelo J, Tato P. Discrimination between active and inactive neurocysticercosis by metacestode excretory/secretory antigens of Taenia solium in an enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 2002;66(6):777-81.
17. Zimic M, Pajuelo M, Rueda D, Lopez C, Arana Y, Castillo Y, et al. Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg. 2009;80(6):964-70.
18. Bueno EC, Scheel CM, Vaz AJ, Machado LR, Livramento JA, Takayanagui OM, et al. Application of synthetic 8-kD and recombinant GP50 antigens in the diagnosis of neurocysticercosis by enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 2005;72(3):278-83.
19. Silva MRM, Maia AAM, Espindola NM, Machado LR, Vaz AJ, Silva FH. Recombinant expression of Taenia solium TS14 antigen and its utilization for immunodiagnosis of neurocysticercosis. Acta Trop. 2006;100(3):192-8.
20. Lee YM, Handali S, Hancock K, Pattabhi S, Kovalenko VA, Levin A, et al. Serologic Diagnosis of Human Taenia soliumCysticercosis by Using Recombinant and Synthetic Antigens in Quick ELISATM. Am J Trop Med Hyg. 2011;84(4):587-93.
21. Hancock K, Khan A, Williams FB, Yushak ML, Pattabhi S, Noh J, et al. Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J Clin Microbiol. 2003;41(6):2577-86.
22. Scheel CM, Khan A, Hancock K, Garcia HH, Gonzalez AE, Gilman RH, et al. Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats. Am J Trop Med Hyg. 2005;73(4):771-6.
23. Bueno EC, Vaz AJ, Machado LD, Livramento JA. Neurocysticercosis: detection of IgG, IgA and IgE antibodies in cerebrospinal fluid, serum and saliva samples by ELISA with Taenia solium and Taenia crassiceps antigens. Arq Neuro-psiquiatr. 2000;58(1):18-24.
24. Peralta RH, Vaz AJ, Pardini A, Macedo HW, Machado LR, De Simone SG, et al. Evaluation of an antigen from Taenia crassiceps cysticercus for the serodiagnosis of neurocysticercosis. Acta Trop. 2002;83(2):159-68.
25. Espindola NM, Iha AH, Fernandes I, Takayanagui OM, Machado LR, Livramento JA, et al. Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercusantigens obtained by immunoaffinity chromatography. J Clin Microbiol. 2005;43(7):3178-84.
26. Fleiss A. The architecture of clinical research. Saunders, 1985. In: Ferreira AW, Ávila SLM, editors. Diagnóstico laboratorial das principais doenças infecciosas e auto-imunes. Rio de Janeiro: Guanabara Koogan; 2001.
27. Murrell KO, editor. WHO-FAO-OIE Guidelines for the survaillance prevention and control of taeniosis - cysticercosis. Paris-France: WHO/OIE/FAO; 2005.
28. Benedeti MR, Falavigna DL, Falavigna-Guilherme AL, Araujo SM. Epidemiological and clinical profile of neurocysticercosis patients assisted by the Hospital Universitário Regional de Maringá, Paraná, Brazil. Arq Neuro-psiquiatr. 2007;65(1):124-9.
29. Souza EM, Rosa MA, Levi AMA. Perfil sorológico das amostras com suspeita de cisticercose enviadas ao Instituto Adolfo Lutz Central - São Paulo- período de 2003 a 2007. 44º Congresso da Sociedade Brasileira de Medicina Tropical; 7 de março de 2008. Porto Alegre, RS; 2008. p. 145.
30. Simonetti AB, Teixeira J. Behavior of the indirect immunofluorescence reaction and of cerebrospinal fluid parameters in neurocysticercosis. Arq Neuro-psiquiatr. 1987;45(1):33-43.
31. Serpa JA, Moran A, Goodman JC, Giordano TP, White AC, Jr. Neurocysticercosis in the HIV era: a case report and review of the literature. Am J Trop Med Hyg. 2007;77(1):113-7.
32. Morales J, Velasco T, Tovar V, Fragoso G, Fleury A, Beltran C et al. Castration abd pregnancy of rural pigs significantly increase the prevalence of naturally acquired Taenia solium cysticercosis. Vet Parasitol. 2002;108(1):41-8.
33. Escobedo G, Camacho-Arroyo I, Hernandez-Hernandez OT, Ostoa-Saloma P, Garcia-Varela M, Morales-Montor J. Progesterone induces scolex evagination of the human parasite Taenia solium: evolutionary implications to the host-parasite relationship. J Biomed Biotechnol. 2010; (ID-591079): 1-10.
34. Kelvin EA, Carpio A, Bagiella E, Leslie D, Leon P, Andrews H, et al. The association of host age and gender with inflammation around neurocysticercosis cysts. Ann Trop Med Parasitol. 2009;103(6):487-99.
35. Hancock K, Pattabhi S, Whitfield FW, Yushak ML, Lane WS, Garcia HH, et al. Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol. 2006;147(1):109-17.
36. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989;159(1):50-9.
37. Agência Nacional de Vigilância Sanitária – Anvisa – Pesquisa de produtos para saúde registrados. [acesso 2011 Jan 11]. Disponível em: [http://www7.anvisa.gov.br/datavisa/Consulta_Produto_correlato/rconsulta_produto_internet.asp]
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor 2011 Revista del Instituto Adolfo Lutz